Cleared Traditional

FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3

K946265 · Clinical Controls, Inc. · Hematology
Aug 1995
Decision
244d
Days
Class 2
Risk

About This 510(k) Submission

K946265 is an FDA 510(k) clearance for the FIBRINOGEN HIGH ABNORMAL CONTROL - LEVEL 3, a Plasma, Fibrinogen Control (Class II — Special Controls, product code GIL), submitted by Clinical Controls, Inc. (Grover Beach, US). The FDA issued a Cleared decision on August 24, 1995, 244 days after receiving the submission on December 23, 1994. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7340.

Submission Details

510(k) Number K946265 FDA.gov
FDA Decision Cleared SESE
Date Received December 23, 1994
Decision Date August 24, 1995
Days to Decision 244 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement

Device Classification

Product Code GIL — Plasma, Fibrinogen Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7340

Similar Devices — GIL Plasma, Fibrinogen Control

All 7
N/T PROTEIN CONTROL PY
K962407 · Behring Diagnostics, Inc. · Jul 1996
FIBRINOGEN CONTROL (HUMAN) LEVEL 1, 2, 3
K946193 · More Diagnostics · Aug 1995
PLASMA FIBRINOGEN CONTROL LEVEL 1/LEVEL 2
K935598 · Clinical Controls, Inc. · May 1995
N/T PROTEIN CONTROL PY
K951012 · Behring Diagnostics, Inc. · Apr 1995
LIQUID FIBRINOGEN FDP CONTROL LEVEL 1 & 2
K934741 · Clinical Controls, Inc. · Sep 1994
FIBRINOGEN CONTROL
K915462 · Sigma Diagnostics, Inc. · Mar 1992